Pharmacy Practice and Diabetes Care

Simpson, Scot H.; MacCallum, Lori; Mansell, Kerry

doi:10.1016/j.jcjd.2017.09.005

Cited by 6 publications

(3 citation statements)

References 20 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Evidence shows that the practice of effective care for patients with DM requires much more than heavy technology (medication); it requires a multidisciplinary team [6], and above all, collaborative relationships between professionals [7]. Hepler and Strand (1990) established that the collaboration of the pharmacist with the health team in patient care takes place through the "responsible provision of medication therapy, with the purpose of achieving de nitive results that improve the patient's quality of life" [8].…”

Section: Introductionmentioning

confidence: 99%

Clinical and Humanistic Impact of Pharmacotherapeutic Follow-Up in Patients with Type 1 Diabetes Mellitus Treated Judicially

Mendonça

Oliveira

Belo

et al. 2022

Preprint

View full text Add to dashboard Cite

Background: There is a lack of studies that assess the effectiveness of pharmacotherapeutic follow-up in the context of the judicialization of insulin analogues. Aims: To evaluate the clinical and humanistic impact of pharmacotherapeutic follow-up in patients with type 1 diabetes mellitus who receive insulin analogues by judicial decision in a Brazilian municipality. Methods: A quasi-experimental study of the before-and-after type was carried out through pharmacotherapeutic follow-up. Patients who accepted to participate in the study underwent laboratory tests of glycemic and lipid profile before and after the intervention, and underwent five pharmaceutical consultations. In addition, quality of life and health, knowledge, and skills related to insulin application techniques were analyzed. Results: 28 patients participated in all stages. Of these, most were female (53.6 %), with a mean age of 32.8 ± 11.6 years. After the intervention, there was a reduction in blood glucose levels, blood pressure and increased body mass index. In addition, there was greater knowledge and skills regarding insulin application techniques, improved quality of life, health, greater number of medications used, reduction of pharmacotherapeutic problems and improvement in eating habits. Conclusion: The pharmacotherapeutic follow-up promoted clinical and humanistic benefits, with improvement in quality of life and health.

show abstract

Section: Introductionmentioning

confidence: 99%

Clinical and Humanistic Impact of Pharmacotherapeutic Follow-Up in Patients with Type 1 Diabetes Mellitus Treated Judicially

Mendonça

Oliveira

Belo

et al. 2022

Preprint

View full text Add to dashboard Cite

show abstract

“…Evidence shows that the practice of effective care for patients with DM requires much more than heavy technology (medication); it requires a multidisciplinary team [ 6 ], and above all, collaborative relationships between professionals [ 7 ]. Hepler and Strand [ 8 ] established that the collaboration of the pharmacist with the health team in patient care takes place through the “responsible provision of medication therapy, with the purpose of achieving definitive results that improve the patient's quality of life” [ 8 ].…”

Section: Introductionmentioning

confidence: 99%

Clinical and humanistic impact of pharmacotherapeutic follow-up in patients with type 1 diabetes mellitus treated judicially

Mendonça

Oliveira

Belo

et al. 2022

Diabetol Metab Syndr

View full text Add to dashboard Cite

Background There is a lack of studies that assess the effectiveness of pharmacotherapeutic follow-up in the context of the judicialization of insulin analogues. Aims To evaluate the clinical and humanistic impact of pharmacotherapeutic follow-up in patients with type 1 diabetes mellitus who receive insulin analogues by judicial decision in a Brazilian municipality. Methods A quasi-experimental study of the before-and-after type was carried out through pharmacotherapeutic follow-up. Patients who accepted to participate in the study underwent laboratory tests of glycemic and lipid profile before and after the intervention, and underwent five pharmaceutical consultations. In addition, quality of life and health, knowledge, and skills related to insulin application techniques were analyzed. Results 28 patients participated in all stages. Of these, most were female (53.6%), with a mean age of 32.8 ± 11.6 years. After the intervention, there was a reduction in blood glucose levels, blood pressure, and increased body mass index. In addition, there was greater knowledge and skills regarding insulin application techniques, improved quality of life, health, greater number of medications used, reduction of pharmacotherapeutic problems, and improvement in eating habits. Conclusion The pharmacotherapeutic follow-up promoted clinical and humanistic benefits, with improvement in quality of life and health.

show abstract

“…Dentro desta equipe interdisciplinar, o farmacêutico atua no tratamento do DM utilizando seus conhecimentos sobre os medicamentos, habilidades e julgamento profissional para garantir que as necessidades de cada paciente sejam atendidas 8 . Logo, pode operar nos pontos de atenção primária à saúde utilizando-se do cuidado farmacêutico, modelo de prática centrado no usuário e realizado por meio dos serviços farmacêuticos clínicos.…”

unclassified

Impacto do cuidado farmacêutico nos desfechos clínicos de um paciente com diabetes tipo 2 em uso de insulina: relato de caso

Bayer

Borba

2021

Saúde (Sta. Maria)

View full text Add to dashboard Cite

Na equipe interdisciplinar, o farmacêutico atua no tratamento do diabetes utilizando seus conhecimentos sobre medicamentos para garantir que as necessidades do paciente sejam atendidas. Este estudo objetivou avaliar os desfechos clínicos de um paciente com diabetes tipo 2 (DM2) em uso de insulina, assistido pelo cuidado farmacêutico realizado por residentes em saúde da família, em unidade básica de saúde do município de Piraquara, PR. Trata-se de um relato de caso no qual os dados foram obtidos a parir de um estudo de coorte descritivo. Inicialmente, foram identificados os problemas relacionados à farmacoterapia e após seis meses de acompanhamento farmacoterapêutico obteve-se redução de 2,06% na hemoglobina glicada e de 206 mg/dL na glicemia de jejum. Este relato demonstrou que o cuidado farmacêutico teve impacto positivo sobre o controle metabólico do paciente. São necessários estudos envolvendo amostras maiores para melhor estabelecer o impacto dos serviços farmacêuticos no cuidado ao paciente com DM2.

show abstract

Pharmacy Practice and Diabetes Care

Cited by 6 publications

References 20 publications

Clinical and Humanistic Impact of Pharmacotherapeutic Follow-Up in Patients with Type 1 Diabetes Mellitus Treated Judicially

Clinical and Humanistic Impact of Pharmacotherapeutic Follow-Up in Patients with Type 1 Diabetes Mellitus Treated Judicially

Clinical and humanistic impact of pharmacotherapeutic follow-up in patients with type 1 diabetes mellitus treated judicially

Impacto do cuidado farmacêutico nos desfechos clínicos de um paciente com diabetes tipo 2 em uso de insulina: relato de caso

Contact Info

Product

Resources

About